New pharmaceutical uses for nos inhibitors
CA 2340200 A1 · Owner: Lowe, John Adams Iii · Inventors: Nowakowski, Jolanta; Lowe, John Adams Iii; Volkmann, Robert Alfred
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to new pharmaceutical uses for compounds that exhibit activity as nitric oxide synthase (NOS) inhibitors. Specifically it , relates to the use of NOS inhibitors particularly selective neuronal NOS (N- NOS) inhibitors: (a) alone or in combination with another active agent for the treatment of psoriasis; (b) in combination with an antiinflammatory agent for the treatment of inflammatory disorders; (c) in combination with a narcotic analgesic (<u>e.g.</u>, opiates such as morphine or demerol) for the treatment of pain; (d) alone or in combination with other active agents for the enhancement of cognition; and (e) alone or in combination with other active …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 5, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 5, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 5, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.